Page 116 - சிட்டி குழுமம் உலகளாவிய சந்தைகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
TravelCenters of America Closes New $200 Million Term Loan
businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
Investors, traders ready for diverse primary
bondbuyer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bondbuyer.com Daily Mail and Mail on Sunday newspapers.
Churchill Capital Corp V Announces Pricing of $450 Million Initial Public Offering
News provided by
Share this article
Share this article
NEW YORK, Dec. 15, 2020 /PRNewswire/ Churchill Capital Corp V (the Company ) announced the pricing of its initial public offering of 45,000,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (the NYSE ) under the symbol CCV.U commencing on December 16, 2020. Each unit consists of one share of the Company s Class A common stock and one-fourth of one warrant, each whole warrant entitling the holder thereof to purchase one share of the Company s Class A common stock at an exercise price of $11.50 per share. Once the securities constituting the units begin separate trading, we expect that the Class A common stock and warrants will be listed on the NYSE under the symbols CCV and CCV WS, respectively.
Share:
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) (NASDAQ:CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells, today announced the launch, subject to market conditions, of an underwritten public offering of $100 million of its American Depositary Shares ( ADS ), each representing one ordinary share of Cellectis. In connection with the offering, Cellectis expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the aggregate offering size on the same terms and conditions.
Citigroup, Jefferies and Barclays are acting as joint book-running managers for the offering. In addition, William Blair is acting as lead manager and Kempen & Co is acting as co-manager for the offering.
Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters Option to Purc
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.